Bio Path Holdings Inc expected to post a loss of 49  cents a share - Earnings Preview

Bio Path Holdings

12/05/2021 13:43

* Bio Path Holdings Inc  BPTH.OQ   BPTH.O  is expected to report
results on May 14.
​* Refinitiv's mean analyst estimate for Bio Path Holdings Inc
is for a loss of 49 cents per share. For the same quarter last
year, the company reported a loss of 90 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Bio Path
Holdings Inc is $12.5​, about 55.4% above​ its last closing
price of $5.58. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.78       -0.78      -0.57     Beat    26.9
 Sep. 30 2020  -0.83       -0.83      -0.80     Beat    3.6
 Jun. 30 2020  -0.89       -0.89      -0.55     Beat    38.2​
 Mar. 31 2020              -0.67      -0.90     Missed  -34.3
 Dec.          -0.69​      -0.69      -0.73     Missed  -5.8​
 31​ 2019​                                              
 Sep. 30 2019  -0.74       -0.74      -0.78     Missed  -5.4​
 Jun. 30 2019  -0.60       -0.60      -0.87     Missed  -45
 This summary was machine generated May 12 at 12:43 GMT.  All
figures in US dollars unless otherwise stated